Discover
RNAM
Avidity Biosciences Inc
72.82
2 x 72.70
2 x 72.92
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
72.88 +0.06 (0.08%)
| Ytd | 0.96% | |
| 1y | 149.21% |
72.75
day range
73.04
21.51
52 week range
73.06
| Open | Prev Close | 72.82 | Low | 72.75 | High | 73.04 | Mkt Cap | 11.25B | |
| Vol | 0.00 | Avg Vol | 1.92M | EPS | -4.19 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-11 | 50-d Avg | 72.33 | 200-d Avg | 54.38 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 860.00K | ||
| Revenues (USD) | 860.00K | ||
| Gross Profit | 860.00K | ||
| Operating Expenses | 255.34M | ||
| Research and Development Expense | 166.60M | ||
| Selling, General and Administrative Expense | 88.74M | ||
| Operating Income | -254.48M | ||
| Net Income | -237.10M | ||
| Net Income Common Stock | -237.10M | ||
| Net Income Common Stock (USD) | -237.10M | ||
| Consolidated Income | -237.10M | ||
| Earnings per Basic Share | -1.59 | ||
| Earnings per Basic Share (USD) | -1.59 | ||
| Earnings per Diluted Share | -1.59 | ||
| Earning Before Interest & Taxes (EBIT) | -237.10M | ||
| Earning Before Interest & Taxes (USD) | -237.10M | ||
| Weighted Average Shares | 154.00M | ||
| Weighted Average Shares Diluted | 154.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 385.31M | ||
| Cash and Equivalents (USD) | 385.31M | ||
| Investments | 1.31B | ||
| Investments Current | 1.31B | ||
| Current Assets | 1.80B | ||
| Property, Plant & Equipment Net | 74.61M | ||
| Total Assets | 1.96B | ||
| Debt Current | 3.94M | ||
| Total Debt | 49.25M | ||
| Current Liabilities | 195.45M | ||
| Debt Non-Current | 45.31M | ||
| Total Liabilities | 269.45M | ||
| Accumulated Retained Earnings (Deficit) | -1.58B | ||
| Accumulated Other Comprehensive Income | 2.56M | ||
| Shareholders Equity | 1.69B | ||
| Shareholders Equity (USD) | 1.69B | ||
| Assets Non-Current | 159.58M | ||
| Total Debt (USD) | 49.25M | ||
| Deferred Revenue | 50.33M | ||
| Liabilities Non-Current | 74.00M | ||
| Trade and Non-Trade Payables | 12.40M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.07M | ||
| Net Cash Flow from Financing | -5.09M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 32.36M | ||
| Capital Expenditure | -6.40M | ||
| Issuance (Purchase) of Equity Shares | 7.32M | ||
| Net Cash Flow from Investing | 207.22M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 213.62M | ||
| Net Cash Flow from Operations | -169.77M | ||
| Effect of Exchange Rate Changes on Cash | -1000 | ||
| Share Based Compensation | 43.42M | ||